The use of Toll-like receptor 7/8 agonists as vaccine adjuvants
The use of Toll-like receptor 7/8 agonists as vaccine adjuvants
About this item
Full title
Author / Creator
Publisher
London: Informa Healthcare
Journal title
Language
English
Formats
Publication information
Publisher
London: Informa Healthcare
Subjects
More information
Scope and Contents
Contents
Small molecule Toll-like receptor (TLR) 7/8 agonists have demonstrated potential as vaccine adjuvants, since they directly activate APCs and can enhance both humoral and cellular immune responses, especially Th1 responses. Although the natural ligands for TLR7 and TLR8 are ssRNA, the vast majority of vaccine studies performed thus far have been per...
Alternative Titles
Full title
The use of Toll-like receptor 7/8 agonists as vaccine adjuvants
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A337787915
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A337787915
Other Identifiers
ISSN
1476-0584
E-ISSN
1744-8395
DOI
10.1586/14760584.2013.811208
